Applications including "UV"

LT207 - Anaysis of Antioxidant capacity by post-column HPLC using DPPH radical -

LC Technical Note InertSustain C18
LT205 - Anaysis of stable radical DPPH -

LC Technical Note InertSustainSwift C8
LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LC Technical Note InertSustain AQ-C18 InertSustain PFP
LT198 - Analysis of ergothioneine in shiitake mushrooms by HPLC -

LC Technical Note InertSustain PFP
LT197 - Analysis of capsaicin by HPLC and LC/MS/MS -

LC Technical Note InertSustain C18
LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

LC Technical Note InertSustain AQ-C18
ST030 - Analysis of cyromazine in livestock products -

SPE Technical Note InertSustain C18
LB263 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB206 - Analysis of Paroxetine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil TMS
LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LC InertSearch InertSustain C18
LB099 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB085 - Analysis of Olmesartan medoxomil (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-2
LB031 - Analysis of Preservatives and Sweetener -

LC InertSearch InertSustain Phenyl
LA908 - Analysis of 17 Anti-depressant drugs (InertSustain C18) -

LC InertSearch InertSustain C18
LB916 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB915 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB914 - Analysis of Saxagliptin -

LC InertSearch Inertsil WP300 C18
LB913 - Analysis of Saxagliptin -

LC InertSearch Inertsil WP300 C18
LB912 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB911 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB910 - Analysis of Fatty acids (C18-C26) -

LC InertSearch InertSustain AQ-C18
LB909 - Analysis of Fatty acids (C18-C26) -

LC InertSearch InertSustain AQ-C18
LB908 - Analysis of Fatty acids (C1-C18) -

LC InertSearch InertSustain AQ-C18
LB907 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB906 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB905 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB904 - Analysis of Celecoxib -

LC InertSearch Inertsil Ph-3
LB903 - Analysis of Perospirone hydrochloride -

LC InertSearch InertSustain C18
LB902 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB901 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB900 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustain C8
LB899 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustainSwift C18
LB898 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LC InertSearch InertSustain AQ-C18
LB897 - Analysis of Thiamine Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB896 - Analysis of Triptorelin Pamoate -

LC InertSearch InertSustain C18
LB893 - Analysis of PAHs -

LC InertSearch Inertsil ODS-P
LB892 - Analysis of Chlorophenols -

LC InertSearch InertSustain C18 HP
LB891 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB890 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB886 - Analysis of Glyphosate,Mecoprop,Bromacil -

LC InertSearch InertSustain AX-C18
LB885 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB884 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB883 - Analysis of Paclitaxel -

LC InertSearch InertSustain PFP
LB882 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB881 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB880 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB879 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB878 - Analysis of Mefenamic acid -

LC InertSearch InertSustain C18
LB877 - Analysis of Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB876 - Analysis of Cefoxitin -

LC InertSearch InertSustain C18
LB875 - Analysis of Levofloxacin -

LC InertSearch Inertsil ODS-3
LB874 - Analysis of Captopril and Captopril Disulfide -

LC InertSearch InertSustain AQ-C18
LB873 - Tacrolimus Extended-Release Capsules -

LC InertSearch InertSustain AQ-C18
LB872 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB871 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB870 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB869 - L-Ascorbic acid and Erythorbic acid -

LC InertSearch InertSustain Amide
LB868 - Analysis of Propionic Acid -

LC InertSearch InertSustain C18
LB867 - Analysis of Febuxostat -

LC InertSearch InertSustain C18
LB866 - Analysis of Sucralose -

LC InertSearch InertSustain C18
LB865 - Analysis of Water-soluble vitamins and D-Araboascorbic acid -

LC InertSearch InertSustain C18
LB864 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LC InertSearch InertSustain C18
LB863 - Analysis of BHT_BHA_PG（Analytical Method A） -

LC InertSearch InertSustain C18
LB862 - Analysis of Antioxidants -

LC InertSearch InertSustain C18
LB861 - Analysis of L-Ascorbic acid and Erythorbic acid -

LC InertSearch InertSustain NH2
LB860 - Analysis of Glycyrrhizinate acid -

LC InertSearch InertSustain C18
LB859 - Analysis of Amoxicillin and Clavulanate potassium -

LC InertSearch Inertsil ODS-3
LB858 - Analysis of Natamycin (Analytical Method B) -

LC InertSearch InertSustain C18
LB857 - Analysis of Natamycin (Analytical Method A) -

LC InertSearch InertSustain AQ-C18
LB856 - Analysis of Lithium lactylate -

LC InertSearch InertSustain C8
LB855 - Analysis of 6 kinds of Aldehydes (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain C30
LB854 - Analysis of Naringin and Hesperidin -

LC InertSearch InertSustain AQ-C18
LB853 - Analysis of p-Hydroxybenzoic acid esters -

LC InertSearch InertSustain C18
LB852 - Analysis of Benzoic acid -

LC InertSearch InertSustain C18
LB851 - Analysis of Calcium Pantothenate -

LC InertSearch InertSustain AQ-C18
LB850 - Analysis of Ethylenediaminetetraacetic acid ferric sodium salt trihydrate -

LC InertSearch InertSustain C18
LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB847 - Analysis of Thiuram -

LC InertSearch InertSustain C30
LB846 - Analysis of Tocopheryl acetate -

LC InertSearch InertSustain C18
LB845 - Analysis of L-Ascorbyl palminate and L-Ascorbic Stearate -

LC InertSearch InertSustain C18
LB844 - Analysis of Malic acid -

LC InertSearch InertSphere FA-1
LB843 - Analysis of Fumaric acid -

LC InertSearch InertSphere FA-1
LB842 - Analysis of Acetic acid -

LC InertSearch InertSphere FA-1
LB841 - Analysis of Lactic acid -

LC InertSearch InertSphere FA-1
LB840 - Analysis of Tartaric acid -

LC InertSearch InertSphere FA-1
LB839 - Analysis of Succinic acid -

LC InertSearch InertSphere FA-1
LB838 - Analysis of Citric acid -

LC InertSearch InertSphere FA-1
LB837 - Analysis of Nonsteroidal anti-inflammatory drug -

LC InertSearch InertSustain C30
LB834 - Analysis of Paraoxybenzoic acid esters -

LC InertSearch InertSustain C18
LB833 - Analysis of Methyl Parahydroxybenzoate -

LC InertSearch InertSustain C18
LB832 - Analysis of Nordihydroguaiaretic Acid -

LC InertSearch InertSustain C18
LB831 - Analysis of Nordihydroguaiaretic Acid -

LC InertSearch InertSustain C18
LB830 - Analysis of Azoxystrobin -

LC InertSearch InertSustain C18
LB829 - Analysis of Sulfamethoxazole and Trimethoprim -

LC InertSearch Inertsil WP300 C18
LB826 - Analysis of Nicotinic acid and Nicotinamide (Under the Condition of food additive analysis method in food) -

LC InertSearch InertSustain C18
LB824 - Analysis of kojic acid -

LC InertSearch InertSustain C18
LB823 - Analysis of Glycyrrhiza -

LC InertSearch Inertsil ODS-3
LB820 - Analysis of ATP related compounds and Cyclic nucleotides (InertSustain C30) -

LC InertSearch InertSustain C30
LB819 - Analysis of ATP and Cyclic nucleotide (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB818 - Analysis of Nucleotides and Cyclic nucleotides -

LC InertSearch InertSustain AX-C18
LB809 - Analysis of ATP related compounds and Guanylic acid -

LC InertSearch InertSustain AQ-C18
LB808 - Analysis of Vitamin D -

LC InertSearch InertSustain C30
LB807 - Analysis of Fat-soluble Vitamins -

LC InertSearch InertSustain C30
LB804 - Analysis of Metformin -

LC InertSearch Inertsil CX
LB801 - Analysis of Chloroacetic acid -

LC InertSearch InertSphere FA-1
LB800 - Analysis of 1,3-Dicyclohexylurea -

LC InertSearch InertSustain C18
LB785 - Analysis of Uric Acid and its related compounds -

LC InertSearch InertSustain AX-C18
LB784 - Analysis of ATP and its related compounds -

LC InertSearch InertSustain AX-C18
LB783 - Analysis of UTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB782 - Analysis of GTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB781 - Analysis of CTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB780 - Analysis of ATP and its related compounds -

LC InertSearch InertSustain AX-C18
LB779 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB778 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB775 - Analysis of Cyclic Nucleotide -

LC InertSearch InertSustain AX-C18
LB774 - Analysis of Nucleotide sugars -

LC InertSearch InertSustain AX-C18
LB771 - Analysis of Nucleoside and Nucleic acid base -

LC InertSearch InertSustain AX-C18
LB770 - Analysis of Pyruvic acid and Phosphoenolpyruvic acid -

LC InertSearch InertSustain AX-C18
LB769 - Analysis of Thiamine and Thiamine pyrophosphate -

LC InertSearch InertSustain AX-C18
LB768 - Analysis of Low molecular weight Hyaluronic acid -

LC InertSearch InertSustain AX-C18
LB767 - Analysis of Chondroitin Sulfate -

LC InertSearch InertSustain AX-C18
LB766 - Analysis of Glucuronic acid -

LC InertSearch InertSustain AX-C18
LB765 - Analysis of Sialic acid -

LC InertSearch InertSustain AX-C18
LB764 - Analysis of Organic acids -

LC InertSearch InertSustain AX-C18
LB763 - Analysis of Tryptophan metabolites -

LC InertSearch InertSustain AX-C18
LB762 - Analysis of L-Cysteic acid -

LC InertSearch InertSustain AX-C18
LB761 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch Inertsil ODS-4
LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain AX-C18
LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB757 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB756 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LC InertSearch InertSustainSwift C18
LB754 - Analysis of Saccharin (Under the Condition of the Japanese Pharmacopoeia 18th, Saccharin Sodium Hydrate) -

LC InertSearch Inertsil WP300 C18
LB753 - Analysis of Vitamin E -

LC InertSearch InertSustain C30
LB751 - Analysis ofSulfamethoxazole and Trimethoprim -

LC InertSearch Inertsil WP300 C18
LB732 - Analysis of Peptides -

LC InertSearch InertSustain AX-C18
LB731 - Analysis of Peptides -

LC InertSearch InertSustain AX-C18
LB722 - Analysis of Ethenzamide -

LC InertSearch InertSustain C18
LB721 - Analysis of Acetaminophen -

LC InertSearch InertSustain C18
LB720 - Analysis of Acetylsalicilic acid -

LC InertSearch InertSustain C18
LB719 - Analysis of Unsaturated fatty acids -

LC InertSearch InertSustain C30
LB718 - Analysis of Polycyclic Aromatic Hydrocarbons (PAHs) -

LC InertSearch Inertsil ODS-P
LB717 - Analysis of Polycyclic Aromatic Hydrocarbons (PAHs) -

LC InertSearch InertSustain C30
LL038 - Analysis of cannabinoids -

LC InertSearch InertSustainSwift C18
LL037 - Analysis of cannabinoids -

LC InertSearch InertSustain C18
LL036 - Analysis of cannabinoids -

LC InertSearch Inertsil ODS-HL HP
LB702 - Analysis of ibuprofen -

LC InertSearch InertSustain C18
LB701 - Analysis of chlorpheniramine maleate -

LC InertSearch Inertsil ODS-4
LB700 - Analysis of acetaminophen -

LC InertSearch InertSustain C18
LB696 - Analysis of Trifluoroacetic acid -

LC InertSearch InertSustain AQ-C18
LB695 - Analysis of acetic acid （USP） -

LC InertSearch InertSustainSwift C18
LB690 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
LB686 - Analysis of Chlorogenic acid -

LC InertSearch InertSustain AX-C18
LB684 - Analysis of Saccharin Sodium Hydrate -

LC InertSearch Inertsil WP300 C18
LB683 - Analysis of Saccharin -

LC InertSearch Inertsil WP300 C18
LB682 - Analysis of Acetic acid and Acetic anhydride -

LC InertSearch InertSustainSwift C18
LB681 - Analysis of Moxifloxacin -

LC InertSearch InertSustain Phenylhexyl
LB677 - Analysis of Zebularine and Gemcitabine -

LC InertSearch InertSustain C18 HP
LB676 - Analysis of Anticancer drug and related substances -

LC InertSearch InertSustain PFP HP
LB673 - Analysis of Limonene -

LC InertSearch InertSustain C18
LB672 - Analysis of Stearyl Glycyrrhetinate -

LC InertSearch InertSustainSwift C8
LB669 - Analysis of Rosuvastatin calcium (Under the condition of the Japanese Pharmacopoeia (JP) ) -

LC InertSearch InertSustainSwift C18
LB668 - Analysis of Nitrosoamines (NDMA, NDEA) -

LC InertSearch InertSustain PFP
LB667 - Analysis of Ribonuclease A -

LC InertSearch MonoSelect RP-mAb
LB666 - Analysis of Myoglobin -

LC InertSearch MonoSelect RP-mAb
LB665 - Analysis of Lysozyme -

LC InertSearch MonoSelect RP-mAb
LB664 - Analysis of Insulin -

LC InertSearch MonoSelect RP-mAb
LB663 - Analysis of IgG -

LC InertSearch MonoSelect RP-mAb
LB662 - Analysis of HSA -

LC InertSearch MonoSelect RP-mAb
LB661 - Analysis of BSA -

LC InertSearch MonoSelect RP-mAb
LB660 - Analysis of Copovidone(Under the Condition of European Pharmacopoeia 10.0, Impurity A) -

LC InertSearch Inertsil ODS-4
LB659 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LC InertSearch Inertsil ODS-HL
LB658 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LC InertSearch Inertsil ODS-HL
LB657 - Analysis of Peptides -

LC InertSearch InertSustain PFP
LB656 - Analysis of Peptides -

LC InertSearch InertSustain AQ-C18
LB655 - Analysis of Peptides -

LC InertSearch InertSustain C18
LB654 - Analysis of Peptides -

LC InertSearch InertSustain Amide
LB653 - Analysis of Oligonucleotides -

LC InertSearch InertSustain Amide
LB652 - Analysis of UTP and its related compounds -

LC InertSearch InertSustain Amide
LB651 - Analysis of GTP and its related compounds -

LC InertSearch InertSustain Amide
LB650 - Analysis of CTP and its related compounds -

LC InertSearch InertSustain Amide
LB649 - Analysis of ATP and its related compounds -

LC InertSearch InertSustain Amide
LB648 - Analysis of Nucleotide sugars -

LC InertSearch InertSustain Amide
LB647 - Analysis of Nicotinamide Adenine Dinucleotide (NADH, NAD+) -

LC InertSearch InertSustain Amide
LB646 - Analysis of Nucleotides and Nucleosides -

LC InertSearch InertSustain Amide
LB645 - Analysis of Glyphosate and Glufosinate -

LC InertSearch InertSustain Amide
LB644 - Analysis of Methylhippuric acids -

LC InertSearch InertSustain Amide
LB643 - Analysis of Dipeptides -

LC InertSearch InertSustain Amide
LB641 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LC InertSearch InertSustain C18
LB640 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LC InertSearch InertSustain C18
LL032 - Analysis of Abraxane -

LC InertSearch MonoSelect nPEC
LB639 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -

LC InertSearch InertSustainSwift C18
LB638 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -

LC InertSearch InertSustain C18
LB637 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Extended-Release Tablets) -

LC InertSearch InertSustain C8
LB636 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Tablets) -

LC InertSearch InertSustainSwift C18
LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LC InertSearch InertSustain AQ-C18 HP
LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -

LC InertSearch InertSustainSwift C18
LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB632 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB631 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB630 - Analysis of Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB629 - Analysis of Telmisartan (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB628 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (7) 2-Pyrrolidone) -

LC InertSearch Inertsil ODS-3
LB627 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone and vinyl acetate) -

LC InertSearch Inertsil ODS-4
LB626 - Analysis of Prasugrel hydrochloride -

LC InertSearch InertSustain C18
LB625 - Analysis of Prasugrel hydrochloride (Under the Condition of USP42-NF37) -

LC InertSearch InertSustainSwift C18
LB624 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB623 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB622 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -

LC InertSearch InertSustain C18
LB621 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -

LC InertSearch InertSustain C18
LB620 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Tablets) -

LC InertSearch InertSustain C18
LB619 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride) -

LC InertSearch InertSustain C8
LB618 - Analysis of Pregabalin (Under the Condition of USP41-NF36, Pregabalin) -

LC InertSearch Inertsil ODS-3
LB617 - Analysis of Levocetirizine -

LC InertSearch Inertsil SIL-100A
LB616 - Analysis of Levocetirizine (Under the Condition of USP41-NF36, Levocetirizine Dihydrochloride) -

LC InertSearch Inertsil SIL-100A
LB615 - Analysis of Cromolyn (Under the Condition of USP41-NF36, Cromolyn Sodium) -

LC InertSearch InertSustain C18
LB614 - Analysis of L-Ascorbic acid 2-glucoside -

LC InertSearch Inertsil ODS-HL
LB613 - Analysis of Isopropylmethylphenol -

LC InertSearch InertSustain AQ-C18
LB612 - Analysis of Tetracaine -

LC InertSearch InertSustain Cyano
LB611 - Analysis of Sertraline -

LC InertSearch InertSustain Cyano
LB610 - Analysis of Nortriptyline -

LC InertSearch InertSustain Cyano
LB609 - Analysis of Chlorophenols -

LC InertSearch InertSustain Cyano
LB608 - Analysis of Citral -

LC InertSearch InertSustain Cyano
LB607 - Analysis of Plant hormones -

LC InertSearch InertSustain Cyano
LB606 - Analysis of Antihistamines -

LC InertSearch InertSustain Cyano HP
LB605 - Analysis of Antihistamines -

LC InertSearch InertSustain Cyano HP
LB604 - Analysis of Antidepressants -

LC InertSearch InertSustain Cyano HP
LB603 - Analysis of Steroids -

LC InertSearch InertSustain Cyano HP
LB602 - Analysis of Methylhippuric acids -

LC InertSearch InertSustain Cyano HP
LB601 - Analysis of Proteins -

LC InertSearch MonoSelect C18 for HTS
LB599 - Analysis of Hydroquinone, Resorcinol, and Catechol -

LC InertSearch MonoSelect C18 for HTS
LB598 - Analysis of Acephate and Methamidophos -

LC InertSearch MonoSelect C18 for HTS
LB594 - Analysis of Estrogen -

LC InertSearch InertSustain PFP
LB593 - Analysis of Steroids -

LC InertSearch InertSustain PFP
LB591 - Analysis of Antihistamines -

LC InertSearch InertSustain PFP
LB590 - Analysis of Antihistamines -

LC InertSearch InertSustain PFP
LB589 - Analysis of β-blockers -

LC InertSearch InertSustain PFP
LB588 - Analysis of Antidepressants -

LC InertSearch InertSustain PFP
LB587 - Analysis of Eugenol -

LC InertSearch InertSustain PFP
LB586 - Analysis of Sterols -

LC InertSearch InertSustain PFP
LB585 - Analysis of Unsaturated fatty acids -

LC InertSearch InertSustain PFP
LB584 - Analysis of Melamine and its related compounds -

LC InertSearch InertSustain PFP
LB580 - Analysis of Urea, Ornithine, and Arginine -

LC InertSearch InertSustain PFP
LB579 - Analysis of Lysine, Methionine, and Carnitine -

LC InertSearch InertSustain PFP
LB578 - Analysis of Cysteine and its related compounds -

LC InertSearch InertSustain PFP
LB577 - Analysis of Glutathione -

LC InertSearch InertSustain PFP
LB576 - Analysis of Uric Acid and its related compounds -

LC InertSearch InertSustain PFP
LB575 - Analysis of Tryptophan and its related compounds -

LC InertSearch InertSustain PFP
LB574 - Analysis of Catecholamines -

LC InertSearch InertSustain PFP
LB573 - Analysis of Dipeptides -

LC InertSearch InertSustain PFP
LB572 - Analysis of Nucleosides -

LC InertSearch InertSustain PFP
LB571 - Analysis of Nicotinamide Adenine Dinucleotide (NADH, NAD+) -

LC InertSearch InertSustain PFP
LT170 - Analysis of Vitamins D2 and D3 in Foods -

LC Technical Note Inertsil Diol Inertsil ODS-P
LT169 - Vitamin B12 Analysis in Foods by HPLC -

LC Technical Note Inertsil Diol Inertsil WP300 Diol Inertsil ODS-4
LT166 - Simultaneous Analysis of 12 Soybean Isoflavones -

LC Technical Note InertSustainSwift C18
LT163 - Analysis of UV Absorbers in Cosmetic Products -

LC Technical Note InertSustain C18
LT161 - Purification of Ribavirin in Human Serum Using MonoSpin PBA -

LC Technical Note InertSustain AQ‐C18 HP
LT159 - Assay Test for Esomeprazole Magnesium Delayed -Release Capsules under USP Method -

LC Technical Note InertSustain C18
LT157 - Examination of Loading Capacity of Proteins Using MonoSpin C18 -

LC Technical Note InertSustainBio C18
LT156 - Sample Preparation of Peptides and Proteins Using MonoSpin C18 -Obtain High Recovery with Ethanol Elution- -

LC Technical Note InertSustainBio C18
LT134 - How to Use Preparative HPLC - Part 2 (Scaling Up from Analytical HPLC) -

LC Technical Note Inertsil ODS-3
LT133 - How to Use Preparative HPLC - Part 1 Evaluation of loading amount -

LC Technical Note
LT132 - Simultaneous Analysis of Cyanoguanidine and Melamine in Food by LC/MS/MS -

LC Technical Note
LT124 - Analysis of Furfural in Insulating Oil -

LC Technical Note InertSustainSwift C18 InertSustain AQ-C18
LT105 - Selective Isolation of Phosphopeptides -

LC Technical Note
LT104 - Analysis of Paraquat and Diquat in Urine -

LC Technical Note Inertsil ODS-3
LT099 - Analysis of Valsartan -

LC Technical Note InertSustain C18
LT098 - Analysis of Amlodipine -

LC Technical Note Inertsil ODS-4 HP
LT097 - Analysis of Pioglitazone Hydrocloride -

LC Technical Note Inertsil ODS-4 HP
LT096 - Analysis of Atorvastatin Calcium -

LC Technical Note Inertsil C8-4 Inertsil C8-4 HP
LT094 - Analysis of Preservatives in Foods -Third Report- -

LC Technical Note Inertsil ODS-4
LT092 - Analysis of Tranexamic Acid According to the Japanese Pharmacopoeia -

LC Technical Note InertSustain AQ-C18 Inertsil ODS-4
LT090 - Analysis of Uric Acid in Serum -

LC Technical Note Inertsil ODS-4
LT089 - Analysis of Rosmarinic Acid in Perilla Juice -

LC Technical Note Inertsil ODS-4
LT088 - Analysis of Curcumin in Nutrient Drinks -

LC Technical Note Inertsil ODS-4
LT084 - Analysis of Hippuric Acid in Urine by HPLC -

LC Technical Note Inertsil ODS-80A
LT081 - Analysis of Synthetic Sweeteners in Foods -Acesulfame Potassium, Saccharin Sodium, Aspartame- -

LC Technical Note Inertsil ODS-4
LT080 - Analysis of Sennosides in Senna in Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-4
LT076 - Analysis of Preservatives in Foods - Second Report -

LC Technical Note Inertsil ODS-3
LT075 - HPLC Analysis of Preservatives in Foods -

LC Technical Note Inertsil ODS-3
LT074 - Analysis of Niacin in Foods -

LC Technical Note Inertsil ODS-3
LT073 - Analysis of Lycopene in Food by HPLC -

LC Technical Note Inertsil ODS-3
LT070 - Analysis of Furfurals in Foods -

LC Technical Note Inertsil ODS-3
LT069 - Analysis of Diosgenin in Foods -

LC Technical Note Inertsil ODS-SP
LT065 - Analysis of Phenolic Antioxidants in Food by HPLC (2) -

LC Technical Note Inertsil ODS-SP Inertsil Ph-3
LT064 - Analysis of Phenolic Antioxidants in Food by HPLC (1) -

LC Technical Note Inertsil ODS-SP
LT063 - Analysis of Tert Butylhydroquinone (TBHQ) in Foods by HPLC -

LC Technical Note Inertsil ODS-SP
LT061 - Analysis of Polyphenol in Food by HPLC -

LC Technical Note Inertsil ODS-3
LT054 - Analysis of Betaine, myo-Inositol and N-acetyl-D-glucosamine in Food, -

LC Technical Note Inertsil NH2
LT052 - Analysis of Geniposide with a Photodiode Array Detection -

LC Technical Note Inertsil ODS-SP
LT051 - Analysis of Allantoin in Cosmetics Using HILIC HPLC -

LC Technical Note Inertsil HILIC
LT045 - Analysis of Water-soluble Vitamins by HPLC-ECD -

LC Technical Note Inertsil ODS-SP Inertsil ODS-3
LT044 - Analysis of Bufosteroids in Senso In Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-P
LT040 - Analysis of peony (Chinese paeoniflorin) in accordance with the 15th edition of the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-3 Inertsil ODS-SP
LT039 - Analysis of Glycyrrhizic Acid in Licorice According to the Japanese Pharmacopoeia -

LC Technical Note
LT038 - Analysis of Scopolamine and Hyoscyamine in Scopolia Extract in Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-SP
LT034 - Analysis of Vitamin E in Food by HPLC -

LC Technical Note Inertsil NH2
LT033 - Isolation of Vitamin D2 and D3 in Foods by HPLC -

LC Technical Note Inertsil NH2 Inertsil ODS-P
LT023 - Analysis of Catechins in Soft Drink -

LC Technical Note Inertsil ODS-3
LT022 - Introduction to an Aldehyde Analyzer -

LC Technical Note Inertsil ODS-80A
LT021 - Analysis of Coenzyme Q10 in Supplements and Cosmetics -

LC Technical Note Inertsil ODS-3
LT020 - Analysis of L-Carnitine in Supplements and Energy Drinks -

LC Technical Note Inertsil ODS-3
LT019 - Analysis of α-Lipoic Acid in Supplements and Cosmetics -

LC Technical Note Inertsil ODS-3
LT009 - Analysis of Vitamin C in Food by HPLC -

LC Technical Note Inertsil SIL-100A Inertsil NH2
LT005 - Analysis of Fungicides in Citrus Fruits -

LC Technical Note Inertsil ODS-3
LT002 - Analysis of Colorants by HPLC-PDA -

LC Technical Note Inertsil ODS-3
LL031 - Analysis of Coumaric acid and Ferulic acid -

LC InertSearch Inertsil ODS-HL
LL027 - Analysis of Isothiazolinone preservatives -

LC InertSearch InertSustain AQ-C18
LL025 - Analysis of PEGylated liposome -

LC InertSearch Inertsil WP300 Diol
LL023 - Analysis of Triclosan -

LC InertSearch InertSustain C18
LL022 - Analysis of Catechins (InertSustain C18) -

LC InertSearch InertSustain C18
LL021 - Analysis of Catechins (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LL020 - Analysis of Catechins (InertSustain Phenyl) -

LC InertSearch InertSustain Phenyｌ
LL019 - Analysis of Food Colorants (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LL018 - Analysis of Food Colorants (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LL017 - Analysis of Food Colorants (InertSustain C18) -

LC InertSearch InertSustain C18
LL016 - Analysis of Food Colorants (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LL015 - Simultaneous analysis of metabolites using LCMSMS (5) - compounds related to central metabolism part 2 - -

LC InertSearch InertSustain C18
LL014 - Simultaneous analysis of metabolites using LCMSMS (4) - compounds related to central metabolism part 1 - -

LC InertSearch InertSustain C18
LL009 - Analysis of Dipeptide type sweetners -

LC InertSearch Inertsil ODS-4
LL005 - Study of the Behavior of Water-Soluble Vitamins in HILIC on a Diol Column -

LC InertSearch Inertsil HILIC
LL003 - A Non-hazardous Technique to Determine Penicillin G and Penicillin G Procaine in Beef -

LC InertSearch Inertsil WP300 C4
LB570 - Analysis of Steviol glycosides (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives), Stevia Extract) -

LC InertSearch Inertsil NH2
LB569 - Analysis of Steviol glycosides (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives), Stevia Extract) -

LC InertSearch InertSustain NH2
LB568 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Steviol Glycosides) -

LC InertSearch InertSustain AQ-C18
LB567 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Steviol Glycosides) -

LC InertSearch Inertsil ODS-HL
LB566 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Stevia Extract) -

LC InertSearch InertSustain AQ-C18
LB565 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Stevia Extract) -

LC InertSearch Inertsil ODS-HL
LB564 - Analysis of Steviol glycosides (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract Assay) -

LC InertSearch Inertsil NH2
LB563 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LC InertSearch InertSustain AQ-C18
LB562 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LC InertSearch Inertsil ODS-HL
LB561 - Analysis of Neotame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain AQ-C18
LB560 - Analysis of Advantame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain AQ-C18
LB559 - Analysis of Artificial sweeteners -

LC InertSearch InertSustain AQ-C18
LB558 - Analysis of 16 Aldehyde (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain PFP
LB557 - Analysis of 16 Aldehyde (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain PFP
LB556 - Analysis of Mirtazapine -

LC InertSearch InertSustain C18
LB555 - Analysis of Mirtazapine (Under the Condition of draft for USP, Mirtazapine Compounded Oral Suspension, Veterinary) -

LC InertSearch Inertsil ODS-3
LB554 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Orally Disintegrating Tablets) -

LC InertSearch InertSustainSwift C18
LB553 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Tablets) -

LC InertSearch InertSustain C18
LB552 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine) -

LC InertSearch InertSustain C18
LB551 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -

LC InertSearch InertSustainSwift C18
LB550 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -

LC InertSearch InertSustainSwift C18
LB549 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe) -

LC InertSearch InertSustain PFP
LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB541 - Analysis of 6 kinds of Aldehydes Specified in Japanese Offensive Odor Control Law (Detected by Pre-Column Method with DNPH) -

LC InertSearch Inertsil C8-4
LB540 - Analysis of 6 kinds of Aldehydes Specified in Japanese Offensive Odor Control Law (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain PFP
LB539 - Analysis of 6 kinds of Aldehydes Specified in Japanese Offensive Odor Control Law (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain PFP
LB538 - Analysis of Organic acid -

LC InertSearch SYPRON AX-2
LB536 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C18
LB535 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustainSwift C8
LB534 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C8
LB533 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of USP41-NF36, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-3
LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -

LC InertSearch InertSustain C18
LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -

LC InertSearch InertSustain C18
LB529 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc Granules) -

LC InertSearch InertSustain C18
LB528 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc) -

LC InertSearch InertSustain C18
LB527 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-4
LB526 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-4
LB525 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB524 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia supplement II, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB523 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB521 - Analysis of Folic acid -

LC InertSearch InertSustain C18
LB520 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C18
LB519 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustainSwift C18
LB518 - Analysis of Glycyrrhetinic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Monoammonium α-Glycyrrhizinate) -

LC InertSearch InertSustain C18
LB517 - Analysis of Glycyrrhizic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Glycyrrhiza Extracted Powder) -

LC InertSearch InertSustain C18
LB516 - (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -

LC InertSearch InertSustain C18
LB515 - Analysis of Caffeine (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -

LC InertSearch InertSustain C18
LB514 - Analysis of Oligonucleotides -

LC InertSearch InertSustainSwift C18
LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -

LC InertSearch InertSustain C18
LB511 - Analysis of Parabens, Estradiol and Progesterone -

LC InertSearch InertSustainSwift C18
LB510 - Analysis of Estradiol and Progesterone (Under the Condition of the draft for the Japanese Standards of Quasi-drug Ingredients, Placental Extract) -

LC InertSearch InertSustainSwift C18
LB508 - Analysis of Sitagliptin (Under the Condition of the draft for the Japanese Pharmacopoeia, Sitagliptin Phosphate Hydrate) -

LC InertSearch InertSustain Cyano
LB503 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition, (3) Related subatances) -

LC InertSearch InertSustain Cyano
LB502 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain Cyano
LB500 - Analysis of Melamine related compounds -

LC InertSearch InertSustain Amide
LB499 - Analysis of Purine bases -

LC InertSearch InertSustain Amide
LB498 - Analysis of Analysis of Tasty Components -

LC InertSearch InertSustain Amide
LB497 - Analysis of Amino acids -

LC InertSearch InertSustain Amide
LB495 - Analysis of Tyramine and Histamine -

LC InertSearch InertSustain Amide
LB494 - Analysis of Corticosteroids -

LC InertSearch Inertsil ODS-HL
LB493 - Analysis of Tryptophan metabolites -

LC InertSearch InertSustain Amide
LB491 - Analysis of Nucleobases -

LC InertSearch InertSustain Amide
LB490 - Analysis of Nucleosides -

LC InertSearch InertSustain Amide
LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -

LC InertSearch InertSustain C18
LB487 - Analysis of Verapamil Hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Verapamil Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB486 - Analysis of Clomipramine Hydorochloride (Under the Condition of the Japanese Pharmacopoeia, Clomipramine Hydorochloride Tablets) -

LC InertSearch Inertsil ODS-3
LB485 - Analysis of Pyridoxal Phosphate Hydrate (Under the Condition of the Japanese Pharmacopoeia, (4) Related subatances) -

LC InertSearch InertSustain AQ-C18
LB483 - Analysis of Minocycline Hydrochloride (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustainSwift C8
LB482 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch Inertsil ODS-4
LB480 - Analysis of 13 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustain C18
LB477 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (7) Formic acid) -

LC InertSearch InertSphere FA-1
LB476 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph
LB475 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph-3
LB474 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenylhexyl
LB473 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenyl
LB472 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C8
LB471 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB469 - Analysis of Vitamin K（Inertsil ODS-HL） -

LC InertSearch Inertsil ODS-HL
LB468 - Analysis of Vitamin K（InertSustainSwift C8） -

LC InertSearch InertSustainSwift C8
LB467 - Analysis of Vitamin D -

LC InertSearch Inertsil ODS-HL
LB466 - Analysis of Oxalic acid -

LC InertSearch InertSustain Amide
LB465 - Analysis of Fungicides -

LC InertSearch InertSustain C18
LB464 - Analysis of Ultraviolet absorbers -

LC InertSearch InertSustain C18
LB463 - Analysis of Ibuprofen (Under the Condition of USP 39-NF34, Ibuprofen Oral Suspension) -

LC InertSearch InertSustain C8
LB462 - Analysis of Cephalexin (Under the Condition of USP 39-NF34) -

LC InertSearch InertSustain C18
LB461 - Analysis of Phenylephrine Hydrochloride (Under the Condition of USP 39-NF34, Phenylephrine Hydrochloride Injection) -

LC InertSearch InertSustain C18
LB460 - Analysis of Estradiol (Under the Condition of USP 39-NF34) -

LC InertSearch Inertsil ODS-3
LB459 - Analysis of Acetaminophen (Under the Condition of USP 39-NF34, Acetaminophen Capsules) -

LC InertSearch Inertsil ODS-3
LB458 - Analysis of Glyburide (Under the Condition of USP 39-NF34) -

LC InertSearch Inertsil C8
LB457 - Analysis of Hydroxynaphthoquinones -

LC InertSearch InertSustain C18
LB456 - Analysis of Benzenediols -

LC InertSearch InertSustain C18
LB453 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia, Tranexamic acid Capsules) -

LC InertSearch Inertsil ODS-4
LB452 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia, Tranexamic acid Tablets) -

LC InertSearch InertSustain AQ-C18
LB451 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain AQ-C18
LB450 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain AQ-C18
LB449 - Analysis of Lansoprazole(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -

LC InertSearch InertSustain C8
LB447 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (6) 2-Aminophenol and 4-Aminophenol) -

LC InertSearch InertSustainSwift C18 HP
LB446 - Analysis of Hydrocortisone butyrate(Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3 HP
LB445 - Analysis of Pazufloxacin mesilate (Under the Condition of the Japanese Pharmacopoeia 18th edition) -

LC InertSearch Inertsil ODS-3
LB444 - Analysis of Pazufloxacin mesilate(Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-2
LB443 - Analysis of Nucleotide -

LC InertSearch InertSustain AQ-C18
LB442 - Analysis of Aflatoxin M1(Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB441 - Analysis of Aflatoxin M1(InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB440 - Analysis of Myoglobin Digests (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB439 - Analysis of Myoglobin Digests (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB438 - Analysis of BSA Digests (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB437 - Analysis of BSA Digests (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB436 - Analysis of Mesalazine(Under the Condition of the Japanese Pharmacopoeia, (7) Aniline) -

LC InertSearch InertSustain C18
LB435 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (6) 2-Pyrrolidone) -

LC InertSearch InertSustain AQ-C18
LB433 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain AQ-C18
LB432 - Analysis of Haloperidol(Under the Condition of the Japanese Pharmacopoeia 17th edition, Haloperidol Tablets) -

LC InertSearch Inertsil ODS-4
LB431 - Analysis of Haloperidol(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch Inertsil ODS-4
LB430 - Analysis of Tulobuterol Hydrochloride(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB429 - Analysis of Tulobuterol(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB428 - Analysis of Zonisamide -

LC InertSearch InertSustain AQ-C18
LB427 - Analysis of Zonisamide -

LC InertSearch InertSustain AQ-C18
LB426 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB425 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB424 - Analysis of Eplerenone(Under the Condition of the Japanese Pharmacopoeia 17th edition, Eplerenone Tablets) -

LC InertSearch Inertsil ODS-3
LB423 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain Phenyl） -

LC InertSearch InertSustain Phenyl
LB422 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain C18） -

LC InertSearch InertSustain C18
LB421 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain Phenylhexyl） -

LC InertSearch InertSustain Phenylhexyl
LB420 - Analysis of Acetaminophen (Under the Condition of the Japanese Pharmacopoeia) （InertSustainSwift C18） -

LC InertSearch InertSustainSwift C18
LB419 - Analysis of Acetaminophen (Under the Condition of the Japanese Pharmacopoeia) （InertSustain C18） -

LC InertSearch InertSustain C18
LB418 - Analysis of Vitamin K (Inertsil WP300 C18) -

LC InertSearch Inertsil WP300 C18
LB417 - Analysis of Vitamin K (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB416 - Analysis of Vitamin K (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB415 - Analysis of Methotrexate (Under the Condition of the draft for the Japanese Pharmacopoeia, Methotrexate Tablets) -

LC InertSearch Inertsil ODS-4
LB414 - Analysis of Esomeprazole magnesium (Under the Condition of USP 38-NF33, Esomeprazole magnesium Extended-release Tablets) -

LC InertSearch InertSustain C18
LB413 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB412 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB411 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB410 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB409 - Analysis of Mesalazine (Under the Condition of the draft for the Japanese Pharmacopoeia, Mesalazine Extended-release Tablets) -

LC InertSearch Inertsil ODS-4
LB408 - Analysis of Fluconazole (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB407 - Analysis of Fluconazole (Under the Condition of the Japanese Pharmacopoeia, Fluconazole Capsules) -

LC InertSearch Inertsil WP300 C18
LB406 - Analysis of Hippuric acid -

LC InertSearch InertSustain AQ-C18 HP
LB405 - Analysis of Phenolic antioxidants -

LC InertSearch InertSustainSwift C18
LB404 - Analysis of Preservatives and Sweetener (Inertsil ODS-SP) -

LC InertSearch Inertsil ODS-SP
LB403 - Analysis of Preservatives and Sweetener (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB402 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB401 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB400 - Analysis of 9 Drugs (InertSustain C18) -

LC InertSearch InertSustain C18
LB399 - Analysis of 9 Drugs (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB398 - Analysis of 9 Drugs (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB396 - Analysis of Oligonucleotide -

LC InertSearch InertSustainBio C18
LB395 - Analysis of Acetaminophen and Caffeine -

LC InertSearch InertSustainSwift C18
LB394 - Analysis of Methacrylic acid (InertSustain C18) -

LC InertSearch InertSustain C18
LB393 - Analysis of Methacrylic acid (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB392 - Analysis of Methacrylic acid (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB386 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-SP) -

LC InertSearch Inertsil ODS-SP
LB385 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB384 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB383 - Analysis of Angiotensin II receptor blockers (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB382 - Analysis of Angiotensin II receptor blockers (InertSustain C18) -

LC InertSearch InertSustain C18
LB381 - Analysis of Angiotensin II receptor blockers (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB380 - Analysis of ATP related compounds -

LC InertSearch InertSustain AQ-C18
LB378 - Analysis of Hippuric Acids -

LC InertSearch InertSustain AQ-C18 HP
LB377 - Analysis of 13 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustain AQ-C18 HP
LB375 - Analysis of Lidocaine -

LC InertSearch InertSustain C18
LB374 - Analysis of Ampiroxicam (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB373 - Analysis of Cyclophosphamide (Under the Condition of the Japanese Pharmacopoeia, Cyclophosphamide Tablets) -

LC InertSearch InertSustainSwift C18
LB372 - Analysis of Cyclophosphamide (Under the Condition of the Japanese Pharmacopoeia, Cyclophosphamide Tablets) -

LC InertSearch InertSustainSwift C18
LB371 - Analysis of Amlodipine besilate (Under the Condition of the Japanese Pharmacopoeia, Amlodipine Besilate Orally Disintegrating Tablets) -

LC InertSearch InertSustainSwift C18
LB370 - Analysis of Prednisolone (Under the Condition of European Pharmacopoeia 8.2) -

LC InertSearch Inertsil ODS-3
LB369 - Analysis of Capsaicin (Under the Condition of the Japanese Pharmacopoeia, Capsicum Tincture) -

LC InertSearch InertSustain Phenyl
LB368 - Analysis of Nucleoside and Nucleic acid base (InertSustain C18) -

LC InertSearch InertSustain C18
LB367 - Analysis of Nucleoside and Nucleic acid base (InertSustain C18) -

LC InertSearch InertSustain C18
LB366 - Analysis of Nucleoside and Nucleic acid base (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB365 - Analysis of Nucleoside and Nucleic acid base (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB364 - Analysis of Water-soluble Vitamins -

LC InertSearch InertSustain AQ-C18
LB363 - Analysis of Organic acid -

LC InertSearch InertSustain AQ-C18
LB362 - Analysis of β-blocker -

LC InertSearch InertSustain AQ-C18
LB361 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB360 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia, Roxithromycin Tablets) -

LC InertSearch InertSustain C18
LB359 - Analysis of EPA and DHA -

LC InertSearch InertSustain C18
LB358 - Analysis of EPA and DHA (InertSustain C18) -

LC InertSearch InertSustain C18
LB357 - Analysis of EPA and DHA (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB356 - Analysis of EPA and DHA (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB355 - Analysis of 7 fatty acids -

LC InertSearch InertSustain C18
LB354 - Analysis of 7 fatty acids -

LC InertSearch InertSustain C18
LB353 - Analysis of 7 fatty acids -

LC InertSearch InertSustain C18
LB352 - Analysis of 7 fatty acids (InertSustain C18) -

LC InertSearch InertSustain C18
LB351 - Analysis of 7 fatty acids (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB350 - Analysis of 7 fatty acids (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB349 - Analysis of Sodium Propionate (InertSustain C18) -

LC InertSearch InertSustain C18
LB348 - Analysis of Sodium Propionate (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB343 - Analysis of Furfral and 5-Hydroxymethylfurfral (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB342 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB341 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustain C18) -

LC InertSearch InertSustain C18
LB340 - Analysis of Chelating compounds -

LC InertSearch InertSustain C18
LB339 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia, Rebamipide Tablets) -

LC InertSearch InertSustain C18
LB338 - Analysis of Chlorhexidine gluconate solution -

LC InertSearch Inertsil ODS-4
LB335 - Analysis of Taurine derivatized with Dansyl Chloride (DNS-Cl) -

LC InertSearch InertSustain C18
LB334 - Analysis of Acrylamide, Acrylonitrile and Organic acids -

LC InertSearch Inertsil ODS-4
LB333 - Analysis of Amygdalin (Inertsil NH2) -

LC InertSearch Inertsil NH2
LB330 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB329 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB328 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia 16th edition supplement II) -

LC InertSearch InertSustainSwift C18
LB327 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia 16th edition) -

LC InertSearch InertSustainSwift C18
LB326 - Analysis of o-Phthalaldehyde (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustainSwift C18
LB325 - Analysis of Glutaraldehyde (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustainSwift C18
LB324 - Analysis of 16 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustainSwift C18
LB323 - Analysis of components of coffee in canned coffee (Inertsil ODS-4 ) -

LC InertSearch Inertsil ODS-4
LB321 - Analysis of components of coffee (Inertsil ODS-4 ) -

LC InertSearch Inertsil ODS-4
LB319 - Analysis of Maleic acid, Fumaric acid and Acrylic acid (Inertsil WP300 C18) -

LC InertSearch Inertsil WP300 C18
LB318 - Analysis of Maleic acid, Fumaric acid and Acrylic acid (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB317 - Separation of Triacylglycerol Positional Isomer -

LC InertSearch Inertsil ODS-P
LB314 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain C18
LB313 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LC InertSearch Inertsil ODS-3
LB312 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LC InertSearch InertSustain C18
LB311 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LC InertSearch Inertsil ODS-3
LB310 - Analysis of Voriconazole (Under the Condition of the Japanese Pharmacopoeia, Voriconazole Tablets) -

LC InertSearch Inertsil WP300 C18
LB309 - Analysis of Voriconazole (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB308 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB307 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB306 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB305 - Analysis of Candesartan cilexetil (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil WP300 C18
LB304 - Analysis of Candesartan cilexetil (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-3
LB303 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB302 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB301 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB300 - Analysis of Candesartan cilexetil (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil WP300 C18
LB299 - Analysis of Candesartan cilexetil (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-3
LB298 - Analysis of Candesartan cilexetil (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB297 - Peptide Separation of Casein Tryptic Digests by Preparative HPLC ODS Column (20 mm I.D.) -

LC InertSearch Inertsil ODS-3
LB295 - Analysis of Irbesartan (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB294 - Analysis of Montelukast sodium -

LC InertSearch InertSustain Phenylhexyl
LB291 - Analysis of Ticlopidine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ticlopidine hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB290 - Analysis of Cefalexin (Under the Condition of the Japanese Pharmacopoeia, Cefalexin Combination Granules) -

LC InertSearch InertSustain C18
LB286 - Analysis of Ribavirin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4 HP
LB285 - Analysis of Ribavirin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4 HP
LB284 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB283 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB282 - Analysis of Povidone (Under the Condition of the Japanese Pharmacopoeia 16th edition, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain C8
LB281 - Analysis of Montelukast sodium (Inertsil Ph) (Under the Condition of the Japanese Pharmacopoeia, Montelukast sodium Tablets) -

LC InertSearch Inertsil Ph
LB279 - Analysis of Indometacin (Under the Condition of European Pharmacopoeia 8.2) -

LC InertSearch InertSustain Phenylhexyl
LB278 - Analysis of Calcium antagonist -

LC InertSearch InertSustain Phenylhexyl
LB277 - Analysis of β-blocker -

LC InertSearch InertSustain Phenylhexyl
LB276 - Analysis of Anti-depressant drugs -

LC InertSearch InertSustain Phenylhexyl
LB275 - Analysis of Histamine antagonist -

LC InertSearch InertSustain Phenylhexyl
LB274 - Analysis of Capsaicin -

LC InertSearch InertSustain Phenylhexyl
LB273 - Analysis of Vitamin B -

LC InertSearch InertSustain Phenylhexyl
LB272 - Analysis of Ibuprofen and Indometacin -

LC InertSearch InertSustain Phenylhexyl
LB270 - Analysis of β-blocker -

LC InertSearch InertSustainSwift C18
LB265 - Analysis of Tacrolimus (Under the Condition of the Japanese Pharmacopoeia, Tacrolimus Capsules) -

LC InertSearch Inertsil ODS-2
LB264 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB262 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C8
LB257 - Analysis of Nucleobase (InertSustain Phenyl) -

LC InertSearch InertSustain Phenyl
LB256 - Analysis of Nucleobase (InertSustain C18) -

LC InertSearch InertSustain C18
LB254 - Analysis of Brotizolam (Under the Condition of the Japanese Pharmacopoeia, Brotizolam Tablets) -

LC InertSearch Inertsil WP300 C18
LB253 - Analysis of Tranilast (Under the Condition of the Japanese Pharmacopoeia, Tranilast Capsules) -

LC InertSearch InertSustain C18
LB252 - Analysis of Glimepiride -

LC InertSearch Inertsil Diol
LB251 - Analysis of Quetiapine fumarate (Under the Condition of the Japanese Pharmacopoeia, Quetiapine fumarate Tablets) -

LC InertSearch Inertsil C8-4
LB250 - Analysis of Azelnidipine (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB249 - Analysis of Organic electroluminescence materials -

LC InertSearch Inertsil ODS-3V
LB248 - Analysis of Organic electroluminescence materials -

LC InertSearch Inertsil ODS-3V
LB247 - Analysis of Terbinafine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Terbinafine hydrochloride Cream) -

LC InertSearch InertSustainSwift C18
LB246 - Analysis of L-Carbocisteine (Under the Condition of the Japanese Pharmacopoeia, L-Carbocisteine Tablets) -

LC InertSearch Inertsil ODS-4
LB245 - Analysis of L-Carbocisteine (Under the Condition of the Japanese Pharmacopoeia, L-Carbocisteine Tablets) -

LC InertSearch Inertsil ODS-4
LB243 - Analysis of Acarbose (Under the Condition of the Japanese Pharmacopoeia, Acarbose Tablets) -

LC InertSearch Inertsil WP300 C18
LB242 - Analysis of Preservatives and Sweetener (Inertsil Ph) -

LC InertSearch Inertsil Ph
LB241 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LC InertSearch InertSustain C18
LB240 - Analysis of Preservatives and Sweetener (InertSustain Phenyl) -

LC InertSearch InertSustain Phenyl
LB239 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB238 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LB237 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LC InertSearch InertSustain C18
LB236 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB235 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LB234 - Analysis of Amino acids -

LC InertSearch InertSustainSwift C18
LB233 - Analysis of Amino acids -

LC InertSearch InertSustainSwift C18
LB232 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18 HP
LB231 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18 HP
LB230 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18 HP
LB228 - Analysis of Polyvinyl alcohol, Polyethyleneglycol and Graft copolymer (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), (3) Acetic acid) -

LC InertSearch InertSustain C18
LB227 - Analysis of Tocopherol (Inertsil ODS-2) -

LC InertSearch Inertsil ODS-2
LB226 - Analysis of Tocopherol (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB225 - Analysis of Tocopherol (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB224 - Analysis of Tocopherol (InertSuatin C18) (Under the Condition of the Japanese Pharmaceutical Codex) -

LC InertSearch InertSustain C18
LB223 - Analysis of Cilnidipine (Under the Condition of the Japanese Pharmacopoeia, Cilnidipine Tablets) -

LC InertSearch Inertsil ODS-4
LB222 - Analysis of Butenafine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18 HP
LB217 - Analysis of 2 kinds of Aldehydes (Inersil ODS-P) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-P
LB216 - Analysis of 2 kinds of Aldehydes (Inersil ODS-SP) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-SP
LB215 - Analysis of 2 kinds of Aldehydes (Inersil ODS) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS
LB214 - Analysis of 2 kinds of Aldehydes (Inersil ODS-2) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-2
LB213 - Analysis of 2 kinds of Aldehydes (Inersil ODS-3) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-3
LB212 - Analysis of 2 kinds of Aldehydes (Inersil ODS-4) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-4
LB211 - Analysis of 2 kinds of Aldehydes (InertSustain C18) (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustain C18
LB210 - Analysis of Pioglitazone hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB209 - Analysis of Pioglitazone hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB208 - Analysis of Montelukast sodium (Oxidative degradation products) -

LC InertSearch InertSustain Phenyl
LB207 - Analysis of Montelukast sodium -

LC InertSearch InertSustain Phenyl
LB205 - Analysis of Paroxetine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Paroxetine hydrochloride Tablets) -

LC InertSearch Inertsil TMS
LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB203 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil Tablets) -

LC InertSearch Inertsil ODS-3
LB202 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil Tablets) -

LC InertSearch Inertsil ODS-3
LB201 - Analysis of Candesartan cilexetil (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB200 - Analysis of Losartan potassium and Hydrochlorothiazide (Under the Condition of USP 35-NF30, Losartan potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB196 - Analysis of Ciprofloxacin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ciprofloxacin hydrochloride hydrate) -

LC InertSearch InertSustain C18
LB195 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB194 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB191 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB190 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB189 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB188 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB187 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB186 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB185 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB184 - Analysis of Phellodendron Bark (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB183 - Analysis of Phellodendron Bark (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB182 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB181 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB178 - Analysis of Hydrochlorothiazide -

LC InertSearch Inertsil WP300 C18
LB177 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 2-pyrrolidone) -

LC InertSearch InertSustain C18
LB176 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain C18
LB175 - Analysis of Loxoprofen (Under the Condition of the Japanese Pharmacopoeia, Loxoprofen sodium Tablets) -

LC InertSearch InertSustain C18
LB174 - Analysis of d-Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB173 - Analysis of Azelastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB167 - Analysis of Crospovidone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB166 - Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia,Pravastatin Sodium Tablets) -

LC InertSearch Inertsil WP300 C18
LB165 - Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia, Pravastatin Sodium Tablets) -

LC InertSearch Inertsil ODS-4
LB164 - Analysis of Telmisartan (Under the Condition of the Japanese Pharmacopoeia, Telmisartan Tablets) -

LC InertSearch Inertsil ODS-4
LB163 - Analysis of Telmisartan (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LB162 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LC InertSearch Inertsil WP300 C18
LB160 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB159 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB158 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB157 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB156 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB155 - Analysis of Amlodipine besylate (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB154 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB153 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-SP
LB152 - Analysis of Epinastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Epinastine Hydrochloride Tablets) -

LC InertSearch Inertsil C8-4
LB148 - Analysis of Cyanocobalamin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB147 - Analysis of Allantoin -

LC InertSearch InertSustain NH2
LB146 - Analysis of Acesulfame potassium -

LC InertSearch InertSustain NH2
LB143 - Analysis of Nucleobase -

LC InertSearch InertSustain NH2
LB139 - Analysis of Nonsteroidal anti-inflammatory drug -

LC InertSearch InertSustain Phenyl
LB138 - Analysis of Steroidal anti-inflammatory drug -

LC InertSearch InertSustain Phenyl
LB137 - Analysis of Estrogen -

LC InertSearch InertSustain Phenyl
LB136 - Analysis of Cresol -

LC InertSearch InertSustain Phenyl
LB135 - Analysis of Methylhippuric acid -

LC InertSearch InertSustain Phenyl
LB134 - Analysis of Fexofenadine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil Ph
LB133 - Analysis of Fexofenadine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil Ph
LB128 - Analysis of Teprenone (Under the Condition of the Japanese Pharmacopoeia, Teprenone Capsules) -

LC InertSearch Inertsil ODS-2
LB127 - Analysis of Etizolam (Under the Condition of the Japanese Pharmacopoeia, Etizolam Tablets) -

LC InertSearch Inertsil ODS-3
LB126 - Analysis of Risperidone (Under the Condition of the Japanese Pharmacopoeia, Risperidone Tablets) -

LC InertSearch Inertsil WP300 C18
LB125 - Analysis of Risperidone (Under the Condition of the Japanese Pharmacopoeia, Risperidone Tablets) -

LC InertSearch Inertsil WP300 C18
LB124 - Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB123 - Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB122 - Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) -

LC InertSearch Inertsil WP300 C18
LB121 - Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) -

LC InertSearch Inertsil WP300 C18
LB120 - Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) -

LC InertSearch Inertsil WP300 C18
LB119 - Analysis of Glimepiride (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB118 - Analysis of Glimepiride (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB117 - Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) -

LC InertSearch Inertsil ODS-4
LB116 - Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) -

LC InertSearch Inertsil ODS-4
LB115 - Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) -

LC InertSearch Inertsil ODS-4
LB114 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB113 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB112 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB111 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB110 - Analysis of Organic acids (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB109 - Analysis of Organic acids (InertSustain C18) -

LC InertSearch InertSustain C18
LB106 - Analysis of Pitavastatin calcium tablets (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB105 - Analysis of Pitavastatin calcium -

LC InertSearch Inertsil ODS-4
LB104 - Analysis of Pitavastatin calcium (Under the Condition of the Japanese Pharmacopoeia, Pitavastatin calcium hydrate) -

LC InertSearch Inertsil ODS-4
LB103 - Analysis of Pilsicainide hydrochloride hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB102 - Analysis of Donepezil hydrochloride (Under the Condition of Japanese Pharmacopoeia, Donepezil hydrochloride tablets) -

LC InertSearch Inertsil ODS-2
LB101 - Analysis of Brotizolam (Under the Condition of the Japanese Pharmacopoeia, Brotizolam tablets) -

LC InertSearch Inertsil WP300 C18
LB100 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB098 - Analysis of p-Hydroxybenzoic acid n-propyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB097 - Analysis of p-Hydroxybenzoic acid ethyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB096 - Analysis of p-Hydroxybenzoic acid methyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB095 - Analysis of Edaravone Injection (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB093 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB092 - Analysis of Edaravone (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB091 - Analysis of Sinigrin (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB089 - Analysis of Phenylenediamine -

LC InertSearch Inertsil ODS-3
LB087 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia, Naftopidil Tablets) -

LC InertSearch InertSustain C18
LB086 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB084 - Analysis of Olmesartan medoxomil (Under the Condition of United States Pharmacopeia 35-NF30) -

LC InertSearch InertSustain C18
LB083 - Analysis of Ranitidine hydrochloride (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch ODS
LB082 - Analysis of Sertraline hydrochloride (Under the Condition of European Pharmacopoeia 7.0) -

LC InertSearch Inertsil ODS-3
LB075 - Analysis of Venlafaxine (InertSustain C18) -

LC InertSearch InertSustain C18
LB074 - Analysis of Rabeprazol (InertSustain C18) -

LC InertSearch InertSustain C18
LB073 - Analysis of Irbesartan (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB072 - Analysis of Ezetimibe (Inertsil C8-4) -

LC InertSearch Inertsil C8-4
LB071 - Analysis of Esomeprazol (InertSustain C18) -

LC InertSearch InertSustain C18
LB069 - Analysis of Rosuvastatin Calcium -

LC InertSearch InertSustain C18
LB068 - Analysis of Olmesartan medoxomil -

LC InertSearch InertSustain C18
LB067 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB066 - Analysis of Mosapride Citrate Tablets (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch InertSustain C18
LB065 - Analysis of Brotizolam(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C8
LB064 - Analysis of Tranilast (Inertsil ODS-4)(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB063 - Analysis of Tranilast (InertSustain C18)(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB062 - Analysis of Cetiridine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Cetiridine hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB061 - Analysis of Sarpogrelate Hydrochloride (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil ODS-2
LB060 - Analysis of Quetiapine Fumarate (Under the Condition of the Japanese Pharmacopoeia, Quetiapine Fumarate Tablets) -

LC InertSearch Inertsil C8-4
LB059 - Analysis of Quetiapine Fumarate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil C8-4
LB058 - Analysis of Amlodipine Besilate (Under the Condition of Japanese Pharmacopoeia, Amlodipine Besilate Tablets) -

LC InertSearch InertSustain C18
LB057 - Analysis of Acetylcysteine (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil ODS-4
LB056 - Analysis of Olopatadine hydrochloride(Under the Condition of Japanese Pharmacopoeia, Olopatadine hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB055 - Analysis of Olopatadine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Olopatadine hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB054 - Analysis of Olopatadine hydrochloride(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB052 - Analysis of Valsartan (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB051 - Analysis of Amlodipine (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB050 - Analysis of Pioglitazone(Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB049 - Analysis of Pioglitazone(Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB047 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB046 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB045 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB044 - Analysis of Pyridine derivatives (InertSustain C8) -

LC InertSearch InertSustain C8
LB037 - Analysis of Terbinafine HCl (Inertsil ODS-4) (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB036 - Analysis of Terbinafine HCl (Inertsil ODS-3) (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB035 - Analysis of Terbinafine HCl (InertSustain C18) (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB034 - Analysis of Nucleotides -

LC InertSearch InertSustain NH2
LB033 - Analysis of Vitamin E -

LC InertSearch InertSustain NH2
LB030 - Analysis of Vitamin K (InertSustain C8) -

LC InertSearch InertSustain C8
LB029 - Analysis of Pitavastatin Calcium -

LC InertSearch InertSustain C18
LB028 - Analysis of Pitavastatin Calcium -

LC InertSearch InertSustain C18
LB027 - Analysis of Pitavastatin Calcium -

LC InertSearch InertSustain C18
LB026 - Analysis of Pitavastatin Calcium -

LC InertSearch InertSustain C18
LB025 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Hydrate) -

LC InertSearch InertSustain C18
LB024 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Tablets) -

LC InertSearch InertSustain C18
LB023 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Tablets) -

LC InertSearch InertSustain C18
LB022 - Analysis of Losartan potassium and Valsartan -

LC InertSearch InertSustain C18
LB021 - Analysis of Valsartan and Hydrochlorothiazide -

LC InertSearch InertSustain C18
LB020 - Analysis of Losartan Potassium and Hydrochlorothiazide -

LC InertSearch InertSustain C8
LB019 - Analysis of Losartan Potassium and Hydrochlorothiazide -

LC InertSearch Inertsil C8-4
LB018 - Analysis of Potassium ferricyanide and Potassium ferrocyanide -

LC InertSearch InertSustain C18
LB017 - Analysis of Furosemide(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB015 - Analysis of Ergosterol(Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB014 - Analysis of Ergosterol(InertSustain C18) -

LC InertSearch InertSustain C18
LB013 - Analysis of Iohexol and Iopamidol -

LC InertSearch InertSustain C18
LA559 - Analysis of Androsterone and Epiandrosterone -

LC InertSearch Inertsil ODS-3
LA522 - Analysis of Resveratrol -

LC InertSearch InertSustain C18
LA303 - Analysis of Pesticides -

LC InertSearch Inertsil ODS-3
LA302 - Analysis of Pesticides -

LC InertSearch Inertsil Ph
LA301 - Analysis of Pesticides -

LC InertSearch Inertsil Ph-3
GA227 - Pesticides -

GC InertSearch InertCap Pesticides
GA226 - Pesticides -

GC InertSearch InertCap Pesticides

Applications including "UV"

LT207 - Anaysis of Antioxidant capacity by post-column HPLC using DPPH radical -

LT205 - Anaysis of stable radical DPPH -

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LT198 - Analysis of ergothioneine in shiitake mushrooms by HPLC -

LT197 - Analysis of capsaicin by HPLC and LC/MS/MS -

LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

ST030 - Analysis of cyromazine in livestock products -

LB263 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LB206 - Analysis of Paroxetine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LB099 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LB085 - Analysis of Olmesartan medoxomil (Under the Condition of the Japanese Pharmacopoeia) -

LB031 - Analysis of Preservatives and Sweetener -

LA908 - Analysis of 17 Anti-depressant drugs (InertSustain C18) -

LB916 - Analysis of Metformin Hydrochloride -

LB915 - Analysis of Metformin Hydrochloride -

LB914 - Analysis of Saxagliptin -

LB913 - Analysis of Saxagliptin -

LB912 - Analysis of Metformin Hydrochloride -

LB911 - Analysis of Metformin Hydrochloride -

LB910 - Analysis of Fatty acids (C18-C26) -

LB909 - Analysis of Fatty acids (C18-C26) -

LB908 - Analysis of Fatty acids (C1-C18) -

LB907 - Analysis of Aripiprazole -

LB906 - Analysis of Aripiprazole -

LB905 - Analysis of Aripiprazole -

LB904 - Analysis of Celecoxib -

LB903 - Analysis of Perospirone hydrochloride -

LB902 - Analysis of Saxagliptin -

LB901 - Analysis of Saxagliptin -

LB900 - Analysis of Fesoterodine Fumarate -

LB899 - Analysis of Fesoterodine Fumarate -

LB898 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LB897 - Analysis of Thiamine Hydrochloride -

LB896 - Analysis of Triptorelin Pamoate -

LB893 - Analysis of PAHs -

LB892 - Analysis of Chlorophenols -

LB891 - Analysis of Saxagliptin -

LB890 - Analysis of Saxagliptin -

LB886 - Analysis of Glyphosate,Mecoprop,Bromacil -

LB885 - Analysis of Voriconazole -

LB884 - Analysis of Voriconazole -

LB883 - Analysis of Paclitaxel -

LB882 - Analysis of Paracetamol and Mefenamic acid -

LB881 - Analysis of Paracetamol and Mefenamic acid -

LB880 - Analysis of Paracetamol and Mefenamic acid -

LB879 - Analysis of Paracetamol and Mefenamic acid -

LB878 - Analysis of Mefenamic acid -

LB877 - Analysis of Mefenamic acid -

LB876 - Analysis of Cefoxitin -

LB875 - Analysis of Levofloxacin -

LB874 - Analysis of Captopril and Captopril Disulfide -

LB873 - Tacrolimus Extended-Release Capsules -

LB872 - Analysis of Febuxostat -

LB871 - Analysis of Febuxostat -

LB870 - Analysis of Febuxostat -

LB869 - L-Ascorbic acid and Erythorbic acid -

LB868 - Analysis of Propionic Acid -

LB867 - Analysis of Febuxostat -

LB866 - Analysis of Sucralose -

LB865 - Analysis of Water-soluble vitamins and D-Araboascorbic acid -

LB864 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LB863 - Analysis of BHT_BHA_PG（Analytical Method A） -

LB862 - Analysis of Antioxidants -

LB861 - Analysis of L-Ascorbic acid and Erythorbic acid -

LB860 - Analysis of Glycyrrhizinate acid -

LB859 - Analysis of Amoxicillin and Clavulanate potassium -

LB858 - Analysis of Natamycin (Analytical Method B) -

LB857 - Analysis of Natamycin (Analytical Method A) -

LB856 - Analysis of Lithium lactylate -

LB855 - Analysis of 6 kinds of Aldehydes (Detected by Pre-Column Method with DNPH) -

LB854 - Analysis of Naringin and Hesperidin -

LB853 - Analysis of p-Hydroxybenzoic acid esters -

LB852 - Analysis of Benzoic acid -

LB851 - Analysis of Calcium Pantothenate -

LB850 - Analysis of Ethylenediaminetetraacetic acid ferric sodium salt trihydrate -

LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -